{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:05:24Z","timestamp":1785542724082,"version":"3.56.0"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018543","name":"Natural Science Foundation of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["XZ2020ZR-ZY55(z)"],"award-info":[{"award-number":["XZ2020ZR-ZY55(z)"]}],"id":[{"id":"10.13039\/501100018543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160157"],"award-info":[{"award-number":["82160157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002095"],"award-info":[{"award-number":["82002095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["202201011129"],"award-info":[{"award-number":["202201011129"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10353-y","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T14:01:54Z","timestamp":1695909714000},"page":"95-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic adaptations in pressure overload hypertrophic heart"],"prefix":"10.1007","volume":"29","author":[{"given":"Jinfeng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-0102","authenticated-orcid":false,"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"10353_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272\u20133287. https:\/\/doi.org\/10.1093\/cvr\/cvac013","journal-title":"Cardiovasc Res"},{"key":"10353_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb AA, Hill BG (2018) Metabolic coordination of physiological and pathological cardiac remodeling. Circ Res 123:107\u2013128. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312017","journal-title":"Circ Res"},{"key":"10353_CR3","doi-asserted-by":"crossref","unstructured":"Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 3:7\u201311. https:\/\/doi.org\/10.15420\/cfr.2016:25:2","DOI":"10.15420\/cfr.2016:25:2"},{"key":"10353_CR4","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA (2023) Heart failure with preserved ejection fraction: a review. JAMA 329:827\u2013838. https:\/\/doi.org\/10.1001\/jama.2023.2020","journal-title":"JAMA"},{"key":"10353_CR5","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED (2021) Cardiac energy metabolism in heart failure. Circ Res 128:1487\u20131513. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318241","journal-title":"Circ Res"},{"key":"10353_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00887-x","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff J, Tian R (2023) Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-023-00887-x","journal-title":"Nat Rev Cardiol"},{"key":"10353_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff J, Tian R (2017) Metabolism in cardiomyopathy: every substrate matters. Cardiovasc Res 113:411\u2013421. https:\/\/doi.org\/10.1093\/cvr\/cvx017","journal-title":"Cardiovasc Res"},{"key":"10353_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/cvr\/cvaa143","volume":"117","author":"KL Ho","year":"2021","unstructured":"Ho KL, Karwi QG, Wagg C, Zhang L, Vo K, Altamimi T, Uddin GM, Ussher JR, Lopaschuk GD (2021) Ketones can become the major fuel source for the heart but do not increase cardiac efficiency. Cardiovasc Res 117:1178\u20131187. https:\/\/doi.org\/10.1093\/cvr\/cvaa143","journal-title":"Cardiovasc Res"},{"key":"10353_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz","year":"2013","unstructured":"Kolwicz SC, Purohit S Jr, Tian R (2013) Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113:603\u2013616. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302095","journal-title":"Circ Res"},{"key":"10353_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, Esparza LA, Reya T, Le Z, Yanxiang GJ, White E, Rabinowitz JD (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551:115\u2013118. https:\/\/doi.org\/10.1038\/nature24057","journal-title":"Nature"},{"key":"10353_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1126\/science.abc8861","volume":"370","author":"D Murashige","year":"2020","unstructured":"Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, Rabinowitz JD, Frankel DS, Arany Z (2020) Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science 370:364\u2013368. https:\/\/doi.org\/10.1126\/science.abc8861","journal-title":"Science"},{"key":"10353_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1196\/annals.1341.019","volume":"1047","author":"H Taegtmeyer","year":"2005","unstructured":"Taegtmeyer H, Wilson CR, Razeghi P, Sharma S (2005) Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 1047:208\u2013218. https:\/\/doi.org\/10.1196\/annals.1341.019","journal-title":"Ann N Y Acad Sci"},{"key":"10353_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cjca.2017.03.009","volume":"33","author":"KA De Jong","year":"2017","unstructured":"De Jong KA, Lopaschuk GD (2017) Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Can J Cardiol 33:860\u2013871. https:\/\/doi.org\/10.1016\/j.cjca.2017.03.009","journal-title":"Can J Cardiol"},{"key":"10353_CR14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00109-022-02269-1","volume":"100","author":"Z Chen","year":"2022","unstructured":"Chen Z, Jin ZX, Cai J, Li R, Deng KQ, Ji YX, Lei F, Li HP, Lu Z, Li H (2022) Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy. J Mol Med 100:1721\u20131739. https:\/\/doi.org\/10.1007\/s00109-022-02269-1","journal-title":"J Mol Med"},{"key":"10353_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"QG Karwi","year":"2018","unstructured":"Karwi QG, Uddin GM, Ho KL, Lopaschuk GD (2018) Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med 5:68. https:\/\/doi.org\/10.3389\/fcvm.2018.00068","journal-title":"Front Cardiovasc Med"},{"key":"10353_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/sj.embor.7400584","volume":"6","author":"CB Dugani","year":"2005","unstructured":"Dugani CB, Klip A (2005) Glucose transporter 4: cycling, compartments and controversies. EMBO Rep 6:1137\u20131142. https:\/\/doi.org\/10.1038\/sj.embor.7400584","journal-title":"EMBO Rep"},{"key":"10353_CR17","doi-asserted-by":"crossref","unstructured":"Kutsche HS, Schreckenberg R, Weber M, Hirschhauser C, Rohrbach S, Li L, Niemann B, Schulz R, Schluter KD (2020) Alterations in Glucose metabolism during the transition to heart failure: the contribution of UCP-2. Cells 9. https:\/\/doi.org\/10.3390\/cells9030552","DOI":"10.3390\/cells9030552"},{"key":"10353_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1582-4934.2011.01307.x","volume":"16","author":"Y Hua","year":"2012","unstructured":"Hua Y, Zhang Y, Ren J (2012) IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med 16:83\u201395. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01307.x","journal-title":"J Cell Mol Med"},{"key":"10353_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0008-6363(95)00019-4","volume":"30","author":"G Paternostro","year":"1995","unstructured":"Paternostro G, Clarke K, Heath J, Seymour AM, Radda GK (1995) Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res 30:205\u2013211","journal-title":"Cardiovasc Res"},{"key":"10353_CR20","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104:2923\u20132931. https:\/\/doi.org\/10.1161\/hc4901.100526","journal-title":"Circulation"},{"key":"10353_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/s0008-6363(98)00233-8","volume":"42","author":"G Paternostro","year":"1999","unstructured":"Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG (1999) Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42:246\u2013253. https:\/\/doi.org\/10.1016\/s0008-6363(98)00233-8","journal-title":"Cardiovasc Res"},{"key":"10353_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1042\/BST20221066","volume":"51","author":"J van Gerwen","year":"2023","unstructured":"van Gerwen J, Shun-Shion AS, Fazakerley DJ (2023) Insulin signalling and GLUT4 trafficking in insulin resistance. Biochem Soc Trans 51:1057\u20131069. https:\/\/doi.org\/10.1042\/BST20221066","journal-title":"Biochem Soc Trans"},{"key":"10353_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","volume":"6","author":"L Zhang","year":"2013","unstructured":"Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD (2013) Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ Heart Fail 6:1039\u20131048. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.000228","journal-title":"Circ Heart Fail"},{"key":"10353_CR24","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","volume":"118","author":"C Riehle","year":"2016","unstructured":"Riehle C, Abel ED (2016) Insulin signaling and heart failure. Circ Res 118:1151\u20131169. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.306206","journal-title":"Circ Res"},{"key":"10353_CR25","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI7605","volume":"104","author":"ED Abel","year":"1999","unstructured":"Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB (1999) Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Investig 104:1703\u20131714. https:\/\/doi.org\/10.1172\/JCI7605","journal-title":"J Clin Investig"},{"key":"10353_CR26","doi-asserted-by":"publisher","first-page":"H1098","DOI":"10.1152\/ajpheart.00101.2017","volume":"313","author":"AR Wende","year":"2017","unstructured":"Wende AR, Kim J, Holland WL, Wayment BE, O\u2019Neill BT, Tuinei J, Brahma MK, Pepin ME, McCrory MA, Luptak I, Halade GV, Litwin SE, Abel ED (2017) Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses. Am J Physiol Heart Circ Physiol 313:H1098\u2013H1108. https:\/\/doi.org\/10.1152\/ajpheart.00101.2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR27","doi-asserted-by":"publisher","first-page":"E420","DOI":"10.1152\/ajpendo.2001.280.3.E420","volume":"280","author":"DD Belke","year":"2001","unstructured":"Belke DD, Larsen TS, Gibbs EM, Severson DL (2001) Glucose metabolism in perfused mouse hearts overexpressing human GLUT-4 glucose transporter. Am J Physiol Endocrinol Metab 280:E420-427. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.3.E420","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10353_CR28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1074\/jbc.270.5.1679","volume":"270","author":"PA Hansen","year":"1995","unstructured":"Hansen PA, Gulve EA, Marshall BA, Gao J, Pessin JE, Holloszy JO, Mueckler M (1995) Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J Biol Chem 270:1679\u20131684. https:\/\/doi.org\/10.1074\/jbc.270.5.1679","journal-title":"J Biol Chem"},{"key":"10353_CR29","doi-asserted-by":"publisher","first-page":"E834","DOI":"10.1152\/ajpendo.00234.2004","volume":"287","author":"J Li","year":"2004","unstructured":"Li J, Hu X, Selvakumar P, 3rd Russell RR, Cushman SW, Holman GD, Young LH (2004) Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 287:E834-841. https:\/\/doi.org\/10.1152\/ajpendo.00234.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10353_CR30","doi-asserted-by":"publisher","first-page":"H643","DOI":"10.1152\/ajpheart.1999.277.2.H643","volume":"277","author":"RR 3rd Russel","year":"1999","unstructured":"3rd Russel RR, Bergeron R, Shulman GI, Young LH (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277:H643-649. https:\/\/doi.org\/10.1152\/ajpheart.1999.277.2.H643","journal-title":"Am J Physiol"},{"key":"10353_CR31","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/hc4001.097183","volume":"104","author":"R Tian","year":"2001","unstructured":"Tian R, Musi N, D\u2019Agostino J, Hirshman MF, Goodyear LJ (2001) Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104:1664\u20131669. https:\/\/doi.org\/10.1161\/hc4001.097183","journal-title":"Circulation"},{"key":"10353_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.yjmcc.2010.12.004","volume":"51","author":"M Kim","year":"2011","unstructured":"Kim M, Tian R (2011) Targeting AMPK for cardiac protection: opportunities and challenges. J Mol Cell Cardiol 51:548\u2013553. https:\/\/doi.org\/10.1016\/j.yjmcc.2010.12.004","journal-title":"J Mol Cell Cardiol"},{"key":"10353_CR33","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1073\/pnas.92.13.5817","volume":"92","author":"S Lund","year":"1995","unstructured":"Lund S, Holman GD, Schmitz O, Pedersen O (1995) Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92:5817\u20135821. https:\/\/doi.org\/10.1073\/pnas.92.13.5817","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 1","key":"10353_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3090001","volume":"309","author":"T Tsakiridis","year":"1995","unstructured":"Tsakiridis T, Vranic M, Klip A (1995) Phosphatidylinositol 3-kinase and the actin network are not required for the stimulation of glucose transport caused by mitochondrial uncoupling: comparison with insulin action. Biochem J 309(Pt 1):1\u20135. https:\/\/doi.org\/10.1042\/bj3090001","journal-title":"Biochem J"},{"key":"10353_CR35","doi-asserted-by":"publisher","unstructured":"Young LH, Coven DL, Russell RR 3rd (2000) Cellular and molecular regulation of cardiac glucose transport. Journal of nuclear cardiology\u202f: official publication of the American Society of Nuclear Cardiology 7:267\u2013276. https:\/\/doi.org\/10.1016\/s1071-3581(00)70016-x","DOI":"10.1016\/s1071-3581(00)70016-x"},{"key":"10353_CR36","doi-asserted-by":"publisher","first-page":"H954","DOI":"10.1152\/ajpheart.00557.2007","volume":"294","author":"L Zhou","year":"2008","unstructured":"Zhou L, Huang H, Yuan CL, Keung W, Lopaschuk GD, Stanley WC (2008) Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. Am J Physiol Heart Circ Physiol 294:H954-960. https:\/\/doi.org\/10.1152\/ajpheart.00557.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0014-5793(02)03552-4","volume":"531","author":"C Beauloye","year":"2002","unstructured":"Beauloye C, Marsin AS, Bertrand L, Vanoverschelde JL, Rider MH, Hue L (2002) The stimulation of heart glycolysis by increased workload does not require AMP-activated protein kinase but a wortmannin-sensitive mechanism. FEBS Lett 531:324\u2013328. https:\/\/doi.org\/10.1016\/s0014-5793(02)03552-4","journal-title":"FEBS Lett"},{"key":"10353_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/157340310793566073","volume":"6","author":"F Heidrich","year":"2010","unstructured":"Heidrich F, Schotola H, Popov AF, Sohns C, Schuenemann J, Friedrich M, Coskun KO, von Lewinski D, Hinz J, Bauer M, Mokashi SA, Sossalla S, Schmitto JD (2010) AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart. Curr Cardiol Rev 6:337\u2013342. https:\/\/doi.org\/10.2174\/157340310793566073","journal-title":"Curr Cardiol Rev"},{"key":"10353_CR39","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1525-1594.2010.01121.x","volume":"34","author":"F Heidrich","year":"2010","unstructured":"Heidrich F, Sossalla S, Schotola H, Vorkamp T, Ortmann P, Popov AF, Coskun KO, Rajab TK, Friedrich M, Sohns C, Hinz J, Bauer M, Quintel M, Schondube FA, Schmitto JD (2010) The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure. Artif Organs 34:969\u2013979. https:\/\/doi.org\/10.1111\/j.1525-1594.2010.01121.x","journal-title":"Artif Organs"},{"key":"10353_CR40","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.106.613646","volume":"114","author":"CS Smith","year":"2006","unstructured":"Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG (2006) Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 114:1151\u20131158. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.613646","journal-title":"Circulation"},{"key":"10353_CR41","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED (2013) Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 113:709\u2013724. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300376","journal-title":"Circ Res"},{"key":"10353_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10741-013-9387-6","volume":"19","author":"M Velez","year":"2014","unstructured":"Velez M, Kohli S, Sabbah HN (2014) Animal models of insulin resistance and heart failure. Heart Fail Rev 19:1\u201313. https:\/\/doi.org\/10.1007\/s10741-013-9387-6","journal-title":"Heart Fail Rev"},{"key":"10353_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3389\/fendo.2019.00881","volume":"10","author":"PRT Bowman","year":"2019","unstructured":"Bowman PRT, Smith GL, Gould GW (2019) Cardiac SNARE Expression in Health and Disease. Front Endocrinol 10:881. https:\/\/doi.org\/10.3389\/fendo.2019.00881","journal-title":"Front Endocrinol"},{"key":"10353_CR44","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1161\/01.cir.0000034049.61181.f3","volume":"106","author":"R Liao","year":"2002","unstructured":"Liao R, Jain M, Cui L, D\u2019Agostino J, Aiello F, Luptak I, Ngoy S, Mortensen RM, Tian R (2002) Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106:2125\u20132131. https:\/\/doi.org\/10.1161\/01.cir.0000034049.61181.f3","journal-title":"Circulation"},{"key":"10353_CR45","doi-asserted-by":"publisher","first-page":"e000301","DOI":"10.1161\/JAHA.113.000301","volume":"2","author":"RO Pereira","year":"2013","unstructured":"Pereira RO, Wende AR, Olsen C, Soto J, Rawlings T, Zhu Y, Anderson SM, Abel ED (2013) Inducible overexpression of GLUT1 prevents mitochondrial dysfunction and attenuates structural remodeling in pressure overload but does not prevent left ventricular dysfunction. J Am Heart Assoc 2:e000301. https:\/\/doi.org\/10.1161\/JAHA.113.000301","journal-title":"J Am Heart Assoc"},{"key":"10353_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yjmcc.2014.02.011","volume":"72","author":"RO Pereira","year":"2014","unstructured":"Pereira RO, Wende AR, Olsen C, Soto J, Rawlings T, Zhu Y, Riehle C, Abel ED (2014) GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure. J Mol Cell Cardiol 72:95\u2013103. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.02.011","journal-title":"J Mol Cell Cardiol"},{"key":"10353_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL (2019) The Hippo pathway: biology and pathophysiology. Annu Rev Biochem 88:577\u2013604. https:\/\/doi.org\/10.1146\/annurev-biochem-013118-111829","journal-title":"Annu Rev Biochem"},{"key":"10353_CR48","doi-asserted-by":"crossref","unstructured":"Gao C, Wang Y (2022) YAP: The nexus between metabolism and cardiac remodeling. J Clin Investig 132. https:\/\/doi.org\/10.1172\/JCI157664","DOI":"10.1172\/JCI157664"},{"key":"10353_CR49","doi-asserted-by":"crossref","unstructured":"Kashihara T, Mukai R, Oka SI, Zhai P, Nakada Y, Yang Z, Mizushima W, Nakahara T, Warren JS, Abdellatif M, Sadoshima J (2022) YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Investig 132. https:\/\/doi.org\/10.1172\/JCI150595","DOI":"10.1172\/JCI150595"},{"key":"10353_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1677\/jme.0.0310449","volume":"31","author":"SJ Kaczmarczyk","year":"2003","unstructured":"Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, Domenighetti AA, Dunn A, Ernst M, Grail D, Fodero-Tavoletti M, Huggins CE, Delbridge LM, Zajac JD, Proietto J (2003) Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 31:449\u2013459. https:\/\/doi.org\/10.1677\/jme.0.0310449","journal-title":"J Mol Endocrinol"},{"key":"10353_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","volume":"8","author":"JD Schilling","year":"2012","unstructured":"Schilling JD, Mann DL (2012) Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin 8:619\u2013631. https:\/\/doi.org\/10.1016\/j.hfc.2012.06.007","journal-title":"Heart Fail Clin"},{"key":"10353_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCRESAHA.117.311307","volume":"122","author":"K Tsushima","year":"2018","unstructured":"Tsushima K, Bugger H, Wende AR, Soto J, Jenson GA, Tor AR, McGlauflin R, Kenny HC, Zhang Y, Souvenir R, Hu XX, Sloan CL, Pereira RO, Lira VA, Spitzer KW, Sharp TL, Shoghi KI, Sparagna GC, Rog-Zielinska EA, Kohl P, Khalimonchuk O, Schaffer JE, Abel ED (2018) Mitochondrial reactive oxygen species in lipotoxic hearts induce post-translational modifications of AKAP121, DRP1, and OPA1 that promote mitochondrial fission. Circ Res 122:58\u201373. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311307","journal-title":"Circ Res"},{"key":"10353_CR53","doi-asserted-by":"crossref","unstructured":"De Geest B, Mishra M (2022) Role of oxidative stress in diabetic cardiomyopathy. Antioxidants 11. https:\/\/doi.org\/10.3390\/antiox11040784","DOI":"10.3390\/antiox11040784"},{"key":"10353_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4314\/ovj.v10i4.2","volume":"10","author":"OD Arkadievich","year":"2021","unstructured":"Arkadievich OD (2021) Metabolic markers of myocardium insulin resistance in dogs with heart failure. Open veterinary journal 10:363\u2013370. https:\/\/doi.org\/10.4314\/ovj.v10i4.2","journal-title":"Open veterinary journal"},{"key":"10353_CR55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/emmm.201200240","volume":"4","author":"R Wu","year":"2012","unstructured":"Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H (2012) Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med 4:633\u2013646. https:\/\/doi.org\/10.1002\/emmm.201200240","journal-title":"EMBO Mol Med"},{"key":"10353_CR56","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","volume":"301","author":"H Tsutsui","year":"2011","unstructured":"Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301:H2181-2190. https:\/\/doi.org\/10.1152\/ajpheart.00554.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.freeradbiomed.2021.02.040","volume":"166","author":"CJA Ramachandra","year":"2021","unstructured":"Ramachandra CJA, Cong S, Chan X, Yap EP, Yu F, Hausenloy DJ (2021) Oxidative stress in cardiac hypertrophy: from molecular mechanisms to novel therapeutic targets. Free Radical Biol Med 166:297\u2013312. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.02.040","journal-title":"Free Radical Biol Med"},{"key":"10353_CR58","doi-asserted-by":"publisher","first-page":"e000355","DOI":"10.1161\/JAHA.113.000355","volume":"2","author":"KS McCommis","year":"2013","unstructured":"McCommis KS, Douglas DL, Krenz M, Baines CP (2013) Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux. J Am Heart Assoc 2. https:\/\/doi.org\/10.1161\/JAHA.113.000355","journal-title":"J Am Heart Assoc"},{"key":"10353_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.119.044452","volume":"142","author":"R Badolia","year":"2020","unstructured":"Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, Krokidi AT, Navankasattusas S, McKellar SH, Yin M, Kfoury AG, Wever-Pinzon O, Fang JC, Selzman CH, Chaudhuri D, Rutter J, Drakos SG (2020) The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure. Circulation 142:259\u2013274. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044452","journal-title":"Circulation"},{"key":"10353_CR60","doi-asserted-by":"publisher","unstructured":"Nakano H, Minami I, Braas D, Pappoe H, Wu X, Sagadevan A, Vergnes L, Fu K, Morselli M, Dunham C, Ding X, Stieg AZ, Gimzewski JK, Pellegrini M, Clark PM, Reue K, Lusis AJ, Ribalet B, Kurdistani SK, Christofk H, Nakatsuji N, Nakano A (2017) Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. eLife 6. https:\/\/doi.org\/10.7554\/eLife.29330","DOI":"10.7554\/eLife.29330"},{"key":"10353_CR61","doi-asserted-by":"publisher","first-page":"H491","DOI":"10.1152\/ajpheart.00721.2012","volume":"304","author":"PA Hecker","year":"2013","unstructured":"Hecker PA, Leopold JA, Gupte SA, Recchia FA, Stanley WC (2013) Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. Am J Physiol Heart Circ Physiol 304:H491-500. https:\/\/doi.org\/10.1152\/ajpheart.00721.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR62","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/01.CIR.0000112605.43318.CA","volume":"109","author":"M Jain","year":"2004","unstructured":"Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, Liao R (2004) Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 109:898\u2013903. https:\/\/doi.org\/10.1161\/01.CIR.0000112605.43318.CA","journal-title":"Circulation"},{"key":"10353_CR63","doi-asserted-by":"publisher","first-page":"H709","DOI":"10.1152\/ajpheart.00783.2013","volume":"306","author":"C Vimercati","year":"2014","unstructured":"Vimercati C, Qanud K, Mitacchione G, Sosnowska D, Ungvari Z, Sarnari R, Mania D, Patel N, Hintze TH, Gupte SA, Stanley WC, Recchia FA (2014) Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. Am J Physiol Heart Circ Physiol 306:H709-717. https:\/\/doi.org\/10.1152\/ajpheart.00783.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR64","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.yjmcc.2006.05.003","volume":"41","author":"SA Gupte","year":"2006","unstructured":"Gupte SA, Levine RJ, Gupte RS, Young ME, Lionetti V, Labinskyy V, Floyd BC, Ojaimi C, Bellomo M, Wolin MS, Recchia FA (2006) Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J Mol Cell Cardiol 41:340\u2013349. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.05.003","journal-title":"J Mol Cell Cardiol"},{"key":"10353_CR65","doi-asserted-by":"publisher","first-page":"984342","DOI":"10.3389\/fendo.2022.984342","volume":"13","author":"M Cairns","year":"2022","unstructured":"Cairns M, Joseph D, Essop MF (2022) The dual role of the hexosamine biosynthetic pathway in cardiac physiology and pathophysiology. Front Endocrinol 13. https:\/\/doi.org\/10.3389\/fendo.2022.984342","journal-title":"Front Endocrinol"},{"key":"10353_CR66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pharmthera.2013.11.005","volume":"142","author":"S Dassanayaka","year":"2014","unstructured":"Dassanayaka S, Jones SP (2014) O-GlcNAc and the cardiovascular system. Pharmacol Ther 142:62\u201371. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.11.005","journal-title":"Pharmacol Ther"},{"key":"10353_CR67","doi-asserted-by":"publisher","unstructured":"Collins HE, Chatham JC (2020) Regulation of cardiac O-GlcNAcylation: more than just nutrient availability. Biochim Biophys Acta Mol Basis Dis\u00a01866:165712. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165712","DOI":"10.1016\/j.bbadis.2020.165712"},{"key":"10353_CR68","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.bbadis.2016.08.012","volume":"1862","author":"F Mailleux","year":"2016","unstructured":"Mailleux F, Gelinas R, Beauloye C, Horman S, Bertrand L (2016) O-GlcNAcylation, enemy or ally during cardiac hypertrophy development? Biochem Biophys Acta 1862:2232\u20132243. https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.012","journal-title":"Biochem Biophys Acta"},{"key":"10353_CR69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1152\/physiolgenomics.00016.2011","volume":"44","author":"IG Lunde","year":"2012","unstructured":"Lunde IG, Aronsen JM, Kvaloy H, Qvigstad E, Sjaastad I, Tonnessen T, Christensen G, Gronning-Wang LM, Carlson CR (2012) Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol Genomics 44:162\u2013172. https:\/\/doi.org\/10.1152\/physiolgenomics.00016.2011","journal-title":"Physiol Genomics"},{"key":"10353_CR70","doi-asserted-by":"publisher","first-page":"17797","DOI":"10.1073\/pnas.1001907107","volume":"107","author":"LJ Watson","year":"2010","unstructured":"Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, Lemma KM, Long BW, Prabhu SD, Xuan YT, Jones SP (2010) O-linked beta-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci USA 107:17797\u201317802. https:\/\/doi.org\/10.1073\/pnas.1001907107","journal-title":"Proc Natl Acad Sci USA"},{"key":"10353_CR71","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1161\/CIRCULATIONAHA.120.051911","volume":"143","author":"P Umapathi","year":"2021","unstructured":"Umapathi P, Mesubi OO, Banerjee PS, Abrol N, Wang Q, Luczak ED, Wu Y, Granger JM, Wei AC, Reyes Gaido OE, Florea L, Talbot CC Jr, Hart GW, Zachara NE, Anderson ME (2021) Excessive O-GlcNAcylation causes heart failure and sudden death. Circulation 143:1687\u20131703. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051911","journal-title":"Circulation"},{"key":"10353_CR72","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","volume":"110","author":"Q Liu","year":"2012","unstructured":"Liu Q, Chen Y, Auger-Messier M, Molkentin JD (2012) Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110:1077\u20131086. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.260729","journal-title":"Circ Res"},{"key":"10353_CR73","doi-asserted-by":"publisher","first-page":"109357","DOI":"10.1016\/j.cellsig.2019.109357","volume":"63","author":"K Dodge-Kafka","year":"2019","unstructured":"Dodge-Kafka K, Gildart M, Tokarski K, Kapiloff MS (2019) mAKAPbeta signalosomes - a nodal regulator of gene transcription associated with pathological cardiac remodeling. Cell Signal 63. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109357","journal-title":"Cell Signal"},{"key":"10353_CR74","doi-asserted-by":"crossref","unstructured":"Han Y, Nie J, Wang DW, Ni L (2022) Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors. Front Cardiovasc Med 9","DOI":"10.3389\/fcvm.2022.931475"},{"key":"10353_CR75","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41467-017-02795-4","volume":"9","author":"R Gelinas","year":"2018","unstructured":"Gelinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des RC, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L (2018) AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nat Commun 9:374. https:\/\/doi.org\/10.1038\/s41467-017-02795-4","journal-title":"Nat Commun"},{"key":"10353_CR76","doi-asserted-by":"crossref","unstructured":"Zhu WZ, El-Nachef D, Yang X, Ledee D, Olson AK (2019) O-GlcNAc transferase promotes compensated cardiac function and protein kinase A O-GlcNAcylation during early and established pathological hypertrophy from pressure overload. J Am Heart Assoc 8","DOI":"10.1161\/JAHA.118.011260"},{"key":"10353_CR77","doi-asserted-by":"publisher","first-page":"1122125","DOI":"10.3389\/fendo.2023.1122125","volume":"14","author":"M Matsuno","year":"2023","unstructured":"Matsuno M, Yokoe S, Nagatsuka T, Morihara H, Moriwaki K, Asahi M (2023) O-GlcNAcylation-induced GSK-3beta activation deteriorates pressure overload-induced heart failure via lack of compensatory cardiac hypertrophy in mice. Front Endocrinol 14:1122125. https:\/\/doi.org\/10.3389\/fendo.2023.1122125","journal-title":"Front Endocrinol"},{"key":"10353_CR78","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00395-017-0612-7","volume":"112","author":"S Dassanayaka","year":"2017","unstructured":"Dassanayaka S, Brainard RE, Watson LJ, Long BW, Brittian KR, DeMartino AM, Aird AL, Gumpert AM, Audam TN, Kilfoil PJ, Muthusamy S, Hamid T, Prabhu SD, Jones SP (2017) Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy. Basic Res Cardiol 112:23. https:\/\/doi.org\/10.1007\/s00395-017-0612-7","journal-title":"Basic Res Cardiol"},{"key":"10353_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41467-023-36712-9","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Qiao S, Zhao Y, Tian H, Yan W, Hou X, Wang R, Zhang B, Yang C, Zhu F, Jiao Y, Jin J, Chen Y, Tian W (2023) The KLF7\/PFKL\/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice. Nat Commun 14:959. https:\/\/doi.org\/10.1038\/s41467-023-36712-9","journal-title":"Nat Commun"},{"key":"10353_CR80","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","volume":"9","author":"J Krishnan","year":"2009","unstructured":"Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit C, Tokarska-Schlattner M, Aasum E, Bogdanova A, Perriard E, Perriard JC, Larsen T, Pedrazzini T, Krek W (2009) Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 9:512\u2013524. https:\/\/doi.org\/10.1016\/j.cmet.2009.05.005","journal-title":"Cell Metab"},{"key":"10353_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD (2017) One-carbon metabolism in health and disease. Cell Metab 25:27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009","journal-title":"Cell Metab"},{"key":"10353_CR82","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jacc.2017.11.067","volume":"71","author":"L Padron-Barthe","year":"2018","unstructured":"Padron-Barthe L, Villalba-Orero M, Gomez-Salinero JM, Acin-Perez R, Cogliati S, Lopez-Olaneta M, Ortiz-Sanchez P, Bonzon-Kulichenko E, Vazquez J, Garcia-Pavia P, Rosenthal N, Enriquez JA, Lara-Pezzi E (2018) Activation of serine one-carbon metabolism by calcineurin abeta1 reduces myocardial hypertrophy and improves ventricular function. J Am Coll Cardiol 71:654\u2013667. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.067","journal-title":"J Am Coll Cardiol"},{"key":"10353_CR83","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.118.037803","volume":"139","author":"H Ma","year":"2019","unstructured":"Ma H, Yu S, Liu X, Zhang Y, Fakadej T, Liu Z, Yin C, Shen W, Locasale JW, Taylor JM, Qian L, Liu J (2019) Lin28a regulates pathological cardiac hypertrophic growth through Pck2-mediated enhancement of anabolic synthesis. Circulation 139:1725\u20131740. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037803","journal-title":"Circulation"},{"key":"10353_CR84","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s1095-6433(03)00007-2","volume":"135","author":"HS Leong","year":"2003","unstructured":"Leong HS, Brownsey RW, Kulpa JE, Allard MF (2003) Glycolysis and pyruvate oxidation in cardiac hypertrophy\u2013why so unbalanced? Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 135:499\u2013513. https:\/\/doi.org\/10.1016\/s1095-6433(03)00007-2","journal-title":"Part A, Molecular & integrative physiology"},{"key":"10353_CR85","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/CIRCRESAHA.118.312660","volume":"122","author":"R Lahey","year":"2018","unstructured":"Lahey R, Carley AN, Wang X, Glass CE, Accola KD, Silvestry S, O\u2019Donnell JM, Lewandowski ED (2018) Enhanced redox state and efficiency of glucose oxidation with miR based suppression of maladaptive NADPH-dependent malic enzyme 1 expression in hypertrophied hearts. Circ Res 122:836\u2013845. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.312660","journal-title":"Circ Res"},{"key":"10353_CR86","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/CIRCRESAHA.108.189951","volume":"104","author":"KM Pound","year":"2009","unstructured":"Pound KM, Sorokina N, Ballal K, Berkich DA, Fasano M, Lanoue KF, Taegtmeyer H, O\u2019Donnell JM, Lewandowski ED (2009) Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ Res 104:805\u2013812. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.189951","journal-title":"Circ Res"},{"key":"10353_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10020-018-0005-x","volume":"24","author":"N Fillmore","year":"2018","unstructured":"Fillmore N, Levasseur JL, Fukushima A, Wagg CS, Wang W, Dyck JRB, Lopaschuk GD (2018) Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. Mol Med 24:3. https:\/\/doi.org\/10.1186\/s10020-018-0005-x","journal-title":"Mol Med"},{"key":"10353_CR88","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/CIRCHEARTFAILURE.112.966705","volume":"5","author":"J Mori","year":"2012","unstructured":"Mori J, Basu R, McLean BA, Das SK, Zhang L, Patel VB, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY (2012) Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Circ Heart Fail 5:493\u2013503. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.966705","journal-title":"Circ Heart Fail"},{"key":"10353_CR89","doi-asserted-by":"publisher","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","volume":"304","author":"J Mori","year":"2013","unstructured":"Mori J, Alrob OA, Wagg CS, Harris RA, Lopaschuk GD, Oudit GY (2013) ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am J Physiol Heart Circ Physiol 304:H1103-1113. https:\/\/doi.org\/10.1152\/ajpheart.00636.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR90","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cvr\/cvs424","volume":"97","author":"P Zhabyeyev","year":"2013","unstructured":"Zhabyeyev P, Gandhi M, Mori J, Basu R, Kassiri Z, Clanachan A, Lopaschuk GD, Oudit GY (2013) Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. Cardiovasc Res 97:676\u2013685. https:\/\/doi.org\/10.1093\/cvr\/cvs424","journal-title":"Cardiovasc Res"},{"key":"10353_CR91","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/s0008-6363(01)00560-0","volume":"53","author":"CP Lydell","year":"2002","unstructured":"Lydell CP, Chan A, Wambolt RB, Sambandam N, Parsons H, Bondy GP, Rodrigues B, Popov KM, Harris RA, Brownsey RW, Allard MF (2002) Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res 53:841\u2013851. https:\/\/doi.org\/10.1016\/s0008-6363(01)00560-0","journal-title":"Cardiovasc Res"},{"key":"10353_CR92","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCGENETICS.113.000404","volume":"7","author":"AA Gupte","year":"2014","unstructured":"Gupte AA, Hamilton DJ, Cordero-Reyes AM, Youker KA, Yin Z, Estep JD, Stevens RD, Wenner B, Ilkayeva O, Loebe M, Peterson LE, Lyon CJ, Wong ST, Newgard CB, Torre-Amione G, Taegtmeyer H, Hsueh WA (2014) Mechanical unloading promotes myocardial energy recovery in human heart failure. Circ Cardiovasc Genet 7:266\u2013276. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000404","journal-title":"Circ Cardiovasc Genet"},{"key":"10353_CR93","doi-asserted-by":"crossref","unstructured":"Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, Olson KA, Taleb I, Tatum SM, Berg JA, Cunningham CN, Van Ry T, Bott AJ, Krokidi AT, Fogarty S, Skedros S, Swiatek WI, Yu X, Luo B, Merx S, Navankasattusas S, Cox JE, Ducker GS, Holland WL, McKellar SH, Rutter J, Drakos SG (2021) The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab 33(629\u2013648)","DOI":"10.1016\/j.cmet.2020.12.003"},{"key":"10353_CR94","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.117.030486","volume":"137","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ji R, Liao X, Castillero E, Kennel PJ, Brunjes DL, Franz M, Mobius-Winkler S, Drosatos K, George I, Chen EI, Colombo PC, Schulze PC (2018) MicroRNA-195 regulates metabolism in failing myocardium via alterations in sirtuin 3 expression and mitochondrial protein acetylation. Circulation 137:2052\u20132067. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030486","journal-title":"Circulation"},{"key":"10353_CR95","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.120.318003","volume":"128","author":"NA Abumrad","year":"2021","unstructured":"Abumrad NA, Cabodevilla AG, Samovski D, Pietka T, Basu D, Goldberg IJ (2021) Endothelial cell receptors in tissue lipid uptake and metabolism. Circ Res 128:433\u2013450. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.318003","journal-title":"Circ Res"},{"key":"10353_CR96","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-physiol-032122-030352","volume":"85","author":"D Samovski","year":"2023","unstructured":"Samovski D, Jacome-Sosa M, Abumrad NA (2023) Fatty acid transport and signaling: mechanisms and physiological implications. Annu Rev Physiol 85:317\u2013337. https:\/\/doi.org\/10.1146\/annurev-physiol-032122-030352","journal-title":"Annu Rev Physiol"},{"key":"10353_CR97","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2337\/diabetes.52.7.1627","volume":"52","author":"JJ Luiken","year":"2003","unstructured":"Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ, Glatz JF (2003) Contraction-induced fatty acid translocase\/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52:1627\u20131634. https:\/\/doi.org\/10.2337\/diabetes.52.7.1627","journal-title":"Diabetes"},{"key":"10353_CR98","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1194\/jlr.R082933","volume":"59","author":"JFC Glatz","year":"2018","unstructured":"Glatz JFC, Luiken J (2018) Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. J Lipid Res 59:1084\u20131093. https:\/\/doi.org\/10.1194\/jlr.R082933","journal-title":"J Lipid Res"},{"key":"10353_CR99","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.1038\/ncomms12837","volume":"7","author":"FL Hsieh","year":"2016","unstructured":"Hsieh FL, Turner L, Bolla JR, Robinson CV, Lavstsen T, Higgins MK (2016) The structural basis for CD36 binding by the malaria parasite. Nat Commun 7:12837. https:\/\/doi.org\/10.1038\/ncomms12837","journal-title":"Nat Commun"},{"key":"10353_CR100","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1093\/nar\/gkq012","volume":"38","author":"DL van der Meer","year":"2010","unstructured":"van der Meer DL, Degenhardt T, Vaisanen S, de Groot PJ, Heinaniemi M, de Vries SC, Muller M, Carlberg C, Kersten S (2010) Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis. Nucleic Acids Res 38:2839\u20132850. https:\/\/doi.org\/10.1093\/nar\/gkq012","journal-title":"Nucleic Acids Res"},{"key":"10353_CR101","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW (2022) The role of CD36 in cardiovascular disease. Cardiovasc Res 118:115\u2013129. https:\/\/doi.org\/10.1093\/cvr\/cvaa319","journal-title":"Cardiovasc Res"},{"key":"10353_CR102","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF01951559","volume":"121","author":"CM Harmon","year":"1991","unstructured":"Harmon CM, Luce P, Beth AH, Abumrad NA (1991) Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport. J Membr Biol 121:261\u2013268. https:\/\/doi.org\/10.1007\/BF01951559","journal-title":"J Membr Biol"},{"key":"10353_CR103","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0022-2275(20)31637-0","volume":"42","author":"T Tanaka","year":"2001","unstructured":"Tanaka T, Nakata T, Oka T, Ogawa T, Okamoto F, Kusaka Y, Sohmiya K, Shimamoto K, Itakura K (2001) Defect in human myocardial long-chain fatty acid uptake is caused by FAT\/CD36 mutations. J Lipid Res 42:751\u2013759","journal-title":"J Lipid Res"},{"key":"10353_CR104","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCHEARTFAILURE.115.002216","volume":"8","author":"S Oka","year":"2015","unstructured":"Oka S, Zhai P, Yamamoto T, Ikeda Y, Byun J, Hsu CP, Sadoshima J (2015) Peroxisome Proliferator activated receptor-alpha association with silent information regulator 1 suppresses cardiac fatty acid metabolism in the failing heart. Circ Heart Fail 8:1123\u20131132. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002216","journal-title":"Circ Heart Fail"},{"key":"10353_CR105","doi-asserted-by":"publisher","first-page":"H681","DOI":"10.1152\/ajpheart.00469.2016","volume":"312","author":"CN Karam","year":"2017","unstructured":"Karam CN, Warren CM, Henze M, Banke NH, Lewandowski ED, Solaro RJ (2017) Peroxisome proliferator-activated receptor-alpha expression induces alterations in cardiac myofilaments in a pressure-overload model of hypertrophy. Am J Physiol Heart Circ Physiol 312:H681\u2013H690. https:\/\/doi.org\/10.1152\/ajpheart.00469.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR106","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.2337\/dc21-2398","volume":"45","author":"E Ferrannini","year":"2022","unstructured":"Ferrannini E, Baldi S, Scozzaro T, Tsimihodimos V, Tesfaye F, Shaw W, Rosenthal N, Figtree GA, Neal B, Mahaffey KW, Perkovic V, Hansen MK (2022) Fasting substrate concentrations predict cardiovascular outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS). Diabetes Care 45:1893\u20131899. https:\/\/doi.org\/10.2337\/dc21-2398","journal-title":"Diabetes Care"},{"key":"10353_CR107","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.119.039610","volume":"139","author":"JR Goldenberg","year":"2019","unstructured":"Goldenberg JR, Carley AN, Ji R, Zhang X, Fasano M, Schulze PC, Lewandowski ED (2019) Preservation of acyl coenzyme A attenuates pathological and metabolic cardiac remodeling through selective lipid trafficking. Circulation 139:2765\u20132777. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.039610","journal-title":"Circulation"},{"key":"10353_CR108","doi-asserted-by":"publisher","first-page":"26443","DOI":"10.1016\/S0021-9258(18)47214-6","volume":"269","author":"BC Weis","year":"1994","unstructured":"Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD (1994) Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269:26443\u201326448","journal-title":"J Biol Chem"},{"key":"10353_CR109","doi-asserted-by":"publisher","first-page":"H2243","DOI":"10.1152\/ajpheart.00864.2003","volume":"286","author":"B Bartelds","year":"2004","unstructured":"Bartelds B, Takens J, Smid GB, Zammit VA, Prip-Buus C, Kuipers JR, van der Leij FR (2004) Myocardial carnitine palmitoyltransferase I expression and long-chain fatty acid oxidation in fetal and newborn lambs. Am J Physiol Heart Circ Physiol 286:H2243-2248. https:\/\/doi.org\/10.1152\/ajpheart.00864.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10353_CR110","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","volume":"126","author":"L He","year":"2012","unstructured":"He L, Kim T, Long Q, Liu J, Wang P, Zhou Y, Ding Y, Prasain J, Wood PA, Yang Q (2012) Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 126:1705\u20131716. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.075978","journal-title":"Circulation"},{"key":"10353_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/CIRCRESAHA.112.274456","volume":"112","author":"ED Lewandowski","year":"2013","unstructured":"Lewandowski ED, Fischer SK, Fasano M, Banke NH, Walker LA, Huqi A, Wang X, Lopaschuk GD, O\u2019Donnell JM (2013) Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy. Circ Res 112:57\u201365. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.274456","journal-title":"Circ Res"},{"key":"10353_CR112","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1194\/jlr.M800147-JLR200","volume":"49","author":"TS Park","year":"2008","unstructured":"Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ (2008) Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49:2101\u20132112. https:\/\/doi.org\/10.1194\/jlr.M800147-JLR200","journal-title":"J Lipid Res"},{"key":"10353_CR113","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yazici","year":"2017","unstructured":"Yazici D, Sezer H (2017) Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol 960:277\u2013304. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_12","journal-title":"Adv Exp Med Biol"},{"key":"10353_CR114","doi-asserted-by":"publisher","first-page":"18443","DOI":"10.1074\/jbc.M117.800839","volume":"292","author":"AS Pereyra","year":"2017","unstructured":"Pereyra AS, Hasek LY, Harris KL, Berman AG, Damen FW, Goergen CJ, Ellis JM (2017) Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy. J Biol Chem 292:18443\u201318456. https:\/\/doi.org\/10.1074\/jbc.M117.800839","journal-title":"J Biol Chem"},{"key":"10353_CR115","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00424-002-0973-z","volume":"445","author":"F Verrey","year":"2003","unstructured":"Verrey F (2003) System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 445:529\u2013533. https:\/\/doi.org\/10.1007\/s00424-002-0973-z","journal-title":"Pflugers Arch"},{"key":"10353_CR116","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41586-019-1503-x","volume":"572","author":"T Yoneshiro","year":"2019","unstructured":"Yoneshiro T, Wang Q, Tajima K, Matsushita M, Maki H, Igarashi K, Dai Z, White PJ, McGarrah RW, Ilkayeva OR, Deleye Y, Oguri Y, Kuroda M, Ikeda K, Li H, Ueno A, Ohishi M, Ishikawa T, Kim K, Chen Y, Sponton CH, Pradhan RN, Majd H, Greiner VJ, Yoneshiro M, Brown Z, Chondronikola M, Takahashi H, Goto T, Kawada T, Sidossis L, Szoka FC, McManus MT, Saito M, Soga T, Kajimura S (2019) BCAA catabolism in brown fat controls energy homeostasis through SLC25A44. Nature 572:614\u2013619. https:\/\/doi.org\/10.1038\/s41586-019-1503-x","journal-title":"Nature"},{"key":"10353_CR117","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","volume":"12","author":"JM Walejko","year":"2021","unstructured":"Walejko JM, Christopher BA, Crown SB, Zhang GF, Pickar-Oliver A, Yoneshiro T, Foster MW, Page S, van Vliet S, Ilkayeva O, Muehlbauer MJ, Carson MW, Brozinick JT, Hammond CD, Gimeno RE, Moseley MA, Kajimura S, Gersbach CA, Newgard CB, White PJ, McGarrah RW (2021) Branched-chain alpha-ketoacids are preferentially reaminated and activate protein synthesis in the heart. Nat Commun 12:1680. https:\/\/doi.org\/10.1038\/s41467-021-21962-2","journal-title":"Nat Commun"},{"key":"10353_CR118","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1096\/fj.201802842RR","volume":"33","author":"D Biswas","year":"2019","unstructured":"Biswas D, Duffley L, Pulinilkunnil T (2019) Role of branched-chain amino acid-catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis. FASEB journal\u202f: official publication of the Federation of American Societies for Experimental Biology 33:8711\u20138731. https:\/\/doi.org\/10.1096\/fj.201802842RR","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10353_CR119","doi-asserted-by":"crossref","unstructured":"White PJ, McGarrah RW, Grimsrud PA, Tso SC, Yang WH, Haldeman JM, Grenier-Larouche T, An J, Lapworth AL, Astapova I, Hannou SA, George T, Arlotto M, Olson LB, Lai M, Zhang GF, Ilkayeva O, Herman MA, Wynn RM, Chuang DT, Newgard CB (2018) The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metab 27(1281\u20131293)","DOI":"10.1016\/j.cmet.2018.04.015"},{"key":"10353_CR120","doi-asserted-by":"publisher","first-page":"23397","DOI":"10.1074\/jbc.M112.351031","volume":"287","author":"M Zhou","year":"2012","unstructured":"Zhou M, Lu G, Gao C, Wang Y, Sun H (2012) Tissue-specific and nutrient regulation of the branched-chain alpha-keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm). J Biol Chem 287:23397\u201323406. https:\/\/doi.org\/10.1074\/jbc.M112.351031","journal-title":"J Biol Chem"},{"key":"10353_CR121","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI38151","volume":"119","author":"G Lu","year":"2009","unstructured":"Lu G, Sun H, She P, Youn JY, Warburton S, Ping P, Vondriska TM, Cai H, Lynch CJ, Wang Y (2009) Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Investig 119:1678\u20131687. https:\/\/doi.org\/10.1172\/JCI38151","journal-title":"J Clin Investig"},{"key":"10353_CR122","doi-asserted-by":"publisher","first-page":"E1046","DOI":"10.1152\/ajpendo.00097.2018","volume":"315","author":"N Fillmore","year":"2018","unstructured":"Fillmore N, Wagg CS, Zhang L, Fukushima A, Lopaschuk GD (2018) Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart. Am J Physiol Endocrinol Metab 315:E1046\u2013E1052. https:\/\/doi.org\/10.1152\/ajpendo.00097.2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10353_CR123","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al BR, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, Oudit GY, Lopaschuk GD (2019) Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol 18:86. https:\/\/doi.org\/10.1186\/s12933-019-0892-3","journal-title":"Cardiovasc Diabetol"},{"key":"10353_CR124","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B, Yang H, Hild M, Kung C, Wilson C, Myer VE, MacKeigan JP, Porter JA, Wang YK, Cantley LC, Finan PM, Murphy LO (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521\u2013534. https:\/\/doi.org\/10.1016\/j.cell.2008.11.044","journal-title":"Cell"},{"key":"10353_CR125","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1101\/gad.1499107","volume":"21","author":"G Lu","year":"2007","unstructured":"Lu G, Ren S, Korge P, Choi J, Dong Y, Weiss J, Koehler C, Chen JN, Wang Y (2007) A novel mitochondrial matrix serine\/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes Dev 21:784\u2013796. https:\/\/doi.org\/10.1101\/gad.1499107","journal-title":"Genes Dev"},{"key":"10353_CR126","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun H, Olson KC, Gao C, Prosdocimo DA, Zhou M, Wang Z, Jeyaraj D, Youn JY, Ren S, Liu Y, Rau CD, Shah S, Ilkayeva O, Gui WJ, William NS, Wynn RM, Newgard CB, Cai H, Xiao X, Chuang DT, Schulze PC, Lynch C, Jain MK, Wang Y (2016) Catabolic defect of branched-chain amino acids promotes heart failure. Circulation 133:2038\u20132049. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.020226","journal-title":"Circulation"},{"key":"10353_CR127","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCRESAHA.121.319817","volume":"131","author":"Z Li","year":"2022","unstructured":"Li Z, Xia H, 3rd Sharp TE, LaPenna KB, Elrod JW, Casin KM, Liu K, Calvert JW, Chau VQ, Salloum FN, Xu S, Xian M, Nagahara N, Goodchild TT, Lefer DJ (2022) Mitochondrial H(2)S regulates BCAA catabolism in heart failure. Circ Res 131:222\u2013235. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319817","journal-title":"Circ Res"},{"key":"10353_CR128","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41401-023-01076-9","volume":"44","author":"JY Yu","year":"2023","unstructured":"Yu JY, Cao N, Rau CD, Lee RP, Yang J, Flach RJR, Petersen L, Zhu C, Pak YL, Miller RA, Liu Y, Wang Y, Li Z, Sun H, Gao C (2023) Cell-autonomous effect of cardiomyocyte branched-chain amino acid catabolism in heart failure in mice. Acta Pharmacol Sin 44:1380\u20131390. https:\/\/doi.org\/10.1038\/s41401-023-01076-9","journal-title":"Acta Pharmacol Sin"},{"key":"10353_CR129","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA (2017) Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab 25:262\u2013284. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.022","journal-title":"Cell Metab"},{"key":"10353_CR130","doi-asserted-by":"crossref","unstructured":"Abdul Kadir A, Clarke K, Evans RD (2020) Cardiac ketone body metabolism. Biochim Biophys Acta Mol Basis Dis 1866","DOI":"10.1016\/j.bbadis.2020.165739"},{"key":"10353_CR131","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","volume":"147","author":"VS Hahn","year":"2023","unstructured":"Hahn VS, Petucci C, Kim MS, Bedi KC Jr, Wang H, Mishra S, Koleini N, Yoo EJ, Margulies KB, Arany Z, Kelly DP, Kass DA, Sharma K (2023) Myocardial metabolomics of human heart failure with preserved ejection fraction. Circulation 147:1147\u20131161. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.061846","journal-title":"Circulation"},{"key":"10353_CR132","doi-asserted-by":"crossref","unstructured":"Flores-Guerrero JL, Westenbrink BD, Connelly MA, Otvos JD, Groothof D, Shalaurova I, Garcia E, Navis G, de Boer RA, Bakker SJL, Dullaart RPF (2021) Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort. Eur J Clin Investig 51","DOI":"10.1111\/eci.13468"},{"key":"10353_CR133","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cvr\/cvz045","volume":"115","author":"KL Ho","year":"2019","unstructured":"Ho KL, Zhang L, Wagg C, Al BR, Gopal K, Levasseur J, Leone T, Dyck JRB, Ussher JR, Muoio DM, Kelly DP, Lopaschuk GD (2019) Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovasc Res 115:1606\u20131616. https:\/\/doi.org\/10.1093\/cvr\/cvz045","journal-title":"Cardiovasc Res"},{"key":"10353_CR134","doi-asserted-by":"crossref","unstructured":"Parreira RC, Gomez-Mendoza DP, de Jesus ICG, Lemos RP, Santos AK, Rezende CP, Figueiredo HCP, Pinto MCX, Kjeldsen F, Guatimosim S, Resende RR, Verano-Braga T (2020) Cardiomyocyte proteome remodeling due to isoproterenol-induced cardiac hypertrophy during the compensated phase. Proteom Clin Appl 14","DOI":"10.1002\/prca.202000017"},{"key":"10353_CR135","doi-asserted-by":"publisher","unstructured":"Uchihashi M, Hoshino A, Okawa Y, Ariyoshi M, Kaimoto S, Tateishi S, Ono K, Yamanaka R, Hato D, Fushimura Y, Honda S, Fukai K, Higuchi Y, Ogata T, Iwai-Kanai E, Matoba S (2017) Cardiac-specific Bdh1 overexpression ameliorates oxidative stress and cardiac remodeling in pressure overload-induced heart failure. Circ Heart Fail 10. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004417","DOI":"10.1161\/CIRCHEARTFAILURE.117.004417"},{"key":"10353_CR136","doi-asserted-by":"publisher","unstructured":"Horton JL, Davidson MT, Kurishima C, Vega RB, Powers JC, Matsuura TR, Petucci C, Lewandowski ED, Crawford PA, Muoio DM, Recchia FA, Kelly DP (2019) The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. JCI Insight 4. https:\/\/doi.org\/10.1172\/jci.insight.124079","DOI":"10.1172\/jci.insight.124079"},{"key":"10353_CR137","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","volume":"133","author":"KC Bedi Jr","year":"2016","unstructured":"Bedi KC Jr, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB, Rame JE (2016) Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation 133:706\u2013716. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017545","journal-title":"Circulation"},{"key":"10353_CR138","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, Koves T, Gardell SJ, Kruger M, Hoppel CL, Lewandowski ED, Crawford PA, Muoio DM, Kelly DP (2016) The failing heart relies on ketone bodies as a fuel. Circulation 133:698\u2013705. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017355","journal-title":"Circulation"},{"key":"10353_CR139","doi-asserted-by":"crossref","unstructured":"Byrne NJ, Soni S, Takahara S, Ferdaoussi M, Al Batran R, Darwesh AM, Levasseur JL, Beker D, Vos DY, Schmidt MA, Alam AS, Maayah ZH, Schertzer JD, Seubert JM, Ussher JR, Dyck JRB (2020) Chronically elevating circulating ketones can reduce cardiac inflammation and blunt the development of heart failure. Circ Heart Fail 13","DOI":"10.1161\/CIRCHEARTFAILURE.119.006573"},{"key":"10353_CR140","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.molmet.2014.07.010","volume":"3","author":"RC Schugar","year":"2014","unstructured":"Schugar RC, Moll AR, Andre DD, Weinheimer CJ, Kovacs A, Crawford PA (2014) Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. Molecular metabolism 3:754\u2013769. https:\/\/doi.org\/10.1016\/j.molmet.2014.07.010","journal-title":"Molecular metabolism"},{"key":"10353_CR141","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biochi.2017.08.001","volume":"143","author":"E Possik","year":"2017","unstructured":"Possik E, Madiraju SRM, Prentki M (2017) Glycerol-3-phosphate phosphatase\/PGP: Role in intermediary metabolism and target for cardiometabolic diseases. Biochimie 143:18\u201328. https:\/\/doi.org\/10.1016\/j.biochi.2017.08.001","journal-title":"Biochimie"},{"key":"10353_CR142","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","volume":"53","author":"MT Nakamura","year":"2014","unstructured":"Nakamura MT, Yudell BE, Loor JJ (2014) Regulation of energy metabolism by long-chain fatty acids. Prog Lipid Res 53:124\u2013144. https:\/\/doi.org\/10.1016\/j.plipres.2013.12.001","journal-title":"Prog Lipid Res"},{"key":"10353_CR143","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00018-022-04466-0","volume":"79","author":"V Zara","year":"2022","unstructured":"Zara V, Assalve G, Ferramosca A (2022) Multiple roles played by the mitochondrial citrate carrier in cellular metabolism and physiology. Cellular and molecular life sciences\u202f: CMLS 79:428. https:\/\/doi.org\/10.1007\/s00018-022-04466-0","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"10353_CR144","doi-asserted-by":"crossref","unstructured":"Wang Y, Yu W, Li S, Guo D, He J, Wang Y (2022) Acetyl-CoA Carboxylases and Diseases. \u00a0Front Oncol 12:836058","DOI":"10.3389\/fonc.2022.836058"},{"key":"10353_CR145","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ, Investigators CO (2023) Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med 388:1353\u20131364. https:\/\/doi.org\/10.1056\/NEJMoa2215024","journal-title":"N Engl J Med"},{"key":"10353_CR146","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jama.2023.9696","volume":"330","author":"SE Nissen","year":"2023","unstructured":"Nissen SE, Menon V, Nicholls SJ, Brennan D, Laffin L, Ridker P, Ray KK, Mason D, Kastelein JJP, Cho L, Libby P, Li N, Foody J, Louie MJ, Lincoff AM (2023) Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA 330:131\u2013140. https:\/\/doi.org\/10.1001\/jama.2023.9696","journal-title":"JAMA"},{"key":"10353_CR147","doi-asserted-by":"publisher","first-page":"19122","DOI":"10.1074\/jbc.M112.345983","volume":"287","author":"SK Mallipattu","year":"2012","unstructured":"Mallipattu SK, Liu R, Zheng F, Narla G, Ma\u2019ayan A, Dikman S, Jain MK, Saleem M, D\u2019Agati V, Klotman P, Chuang PY, He JC (2012) Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation. J Biol Chem 287:19122\u201319135. https:\/\/doi.org\/10.1074\/jbc.M112.345983","journal-title":"J Biol Chem"},{"key":"10353_CR148","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.phrs.2017.12.018","volume":"130","author":"L Fan","year":"2018","unstructured":"Fan L, Hsieh PN, Sweet DR, Jain MK (2018) Kruppel-like factor 15: Regulator of BCAA metabolism and circadian protein rhythmicity. Pharmacol Res 130:123\u2013126. https:\/\/doi.org\/10.1016\/j.phrs.2017.12.018","journal-title":"Pharmacol Res"},{"key":"10353_CR149","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1038\/s41467-018-05362-7","volume":"9","author":"D Shao","year":"2018","unstructured":"Shao D, Villet O, Zhang Z, Choi SW, Yan J, Ritterhoff J, Gu H, Djukovic D, Christodoulou D, Kolwicz SC Jr, Raftery D, Tian R (2018) Glucose promotes cell growth by suppressing branched-chain amino acid degradation. Nat Commun 9:2935. https:\/\/doi.org\/10.1038\/s41467-018-05362-7","journal-title":"Nat Commun"},{"key":"10353_CR150","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/jn\/130.10.2413","volume":"130","author":"JC Anthony","year":"2000","unstructured":"Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR (2000) Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130:2413\u20132419. https:\/\/doi.org\/10.1093\/jn\/130.10.2413","journal-title":"J Nutr"},{"key":"10353_CR151","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10557-022-07320-4","volume":"37","author":"QG Karwi","year":"2023","unstructured":"Karwi QG, Lopaschuk GD (2023) Branched-chain amino acid metabolism in the failing heart. Cardiovasc Drugs Ther 37:413\u2013420. https:\/\/doi.org\/10.1007\/s10557-022-07320-4","journal-title":"Cardiovasc Drugs Ther"},{"key":"10353_CR152","doi-asserted-by":"publisher","unstructured":"Dimou A, Tsimihodimos V, Bairaktari E (2022) The critical role of the branched chain amino acids (BCAAs) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and branched-chain alpha-keto acid dehydrogenase (BCKD), in human pathophysiology. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23074022","DOI":"10.3390\/ijms23074022"},{"key":"10353_CR153","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li T, Zhang Z, Kolwicz SC Jr, Abell L, Roe ND, Kim M, Zhou B, Cao Y, Ritterhoff J, Gu H, Raftery D, Sun H, Tian R (2017) Defective Branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab 25:374\u2013385. https:\/\/doi.org\/10.1016\/j.cmet.2016.11.005","journal-title":"Cell Metab"},{"key":"10353_CR154","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang C, Oh SF, Wada S, Rowe GC, Liu L, Chan MC, Rhee J, Hoshino A, Kim B, Ibrahim A, Baca LG, Kim E, Ghosh CC, Parikh SM, Jiang A, Chu Q, Forman DE, Lecker SH, Krishnaiah S, Rabinowitz JD, Weljie AM, Baur JA, Kasper DL, Arany Z (2016) A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med 22:421\u2013426. https:\/\/doi.org\/10.1038\/nm.4057","journal-title":"Nat Med"},{"key":"10353_CR155","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.120.053365","volume":"144","author":"M Korf-Klingebiel","year":"2021","unstructured":"Korf-Klingebiel M, Reboll MR, Polten F, Weber N, Jackle F, Wu X, Kallikourdis M, Kunderfranco P, Condorelli G, Giannitsis E, Kustikova OS, Schambach A, Pich A, Widder JD, Bauersachs J, van den Heuvel J, Kraft T, Wang Y, Wollert KC (2021) Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco\/endoplasmic reticulum Ca(2+)-ATPase expression in cardiomyocytes. Circulation 144:1227\u20131240. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.053365","journal-title":"Circulation"},{"key":"10353_CR156","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ghir.2005.09.002","volume":"16","author":"H Stromer","year":"2006","unstructured":"Stromer H, Palmieri EA, De Groot MC, Di Rella F, Leupold A, Horn M, Monti MG, Napoli R, Di Gianni A, Isgaard J, Sacca L, Neubauer S, Cittadini A (2006) Growth hormone- and pressure overload-induced cardiac hypertrophy evoke different responses to ischemia-reperfusion and mechanical stretch. Growth hormone & IGF research\u202f: official journal of the Growth Hormone Research Society and the International IGF Research Society 16:29\u201340. https:\/\/doi.org\/10.1016\/j.ghir.2005.09.002","journal-title":"Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society"},{"key":"10353_CR157","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/01.HYP.0000209940.65941.46","volume":"47","author":"MS Mozaffari","year":"2006","unstructured":"Mozaffari MS, Patel C, Schaffer SW (2006) Mechanisms underlying afterload-induced exacerbation of myocardial infarct size: role of T-type Ca2+ channel. Hypertension 47:912\u2013919. https:\/\/doi.org\/10.1161\/01.HYP.0000209940.65941.46","journal-title":"Hypertension"},{"key":"10353_CR158","doi-asserted-by":"crossref","unstructured":"Xu X, Zhen PH, Yu FC, Wang T, Li SN, Wei Q, Tong JY (2022) Chronic intermittent hypoxia accelerates cardiac dysfunction and cardiac remodeling during cardiac pressure overload in mice and can be alleviated by PHD3 overexpression. Front Cardiovasc Med 9","DOI":"10.3389\/fcvm.2022.974345"},{"key":"10353_CR159","doi-asserted-by":"crossref","unstructured":"Ma LL, Kong FJ, Dong Z, Xin KY, Wang XX, Sun AJ, Zou YZ, Ge JB (2021) Hypertrophic preconditioning attenuates myocardial ischaemia-reperfusion injury by modulating SIRT3-SOD2-mROS-dependent autophagy. Cell Prolif 54","DOI":"10.1111\/cpr.13051"},{"key":"10353_CR160","doi-asserted-by":"crossref","unstructured":"Ma LL, Ding ZW, Yin PP, Wu J, Hu K, Sun AJ, Zou YZ, Ge JB (2021) Hypertrophic preconditioning cardioprotection after myocardial ischaemia\/reperfusion injury involves ALDH2-dependent metabolism modulation. Redox Biol 43","DOI":"10.1016\/j.redox.2021.101960"},{"key":"10353_CR161","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.scib.2021.04.008","volume":"66","author":"L Ma","year":"2021","unstructured":"Ma L, Shi H, Li Y, Gao W, Guo J, Zhu J, Dong Z, Sun A, Zou Y, Ge J (2021) Hypertrophic preconditioning attenuates myocardial ischemia\/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2. Sci Bull 66:2099\u20132114. https:\/\/doi.org\/10.1016\/j.scib.2021.04.008","journal-title":"Sci Bull"},{"key":"10353_CR162","doi-asserted-by":"publisher","first-page":"1157472","DOI":"10.3389\/fcvm.2023.1157472","volume":"10","author":"M Correale","year":"2023","unstructured":"Correale M, Tricarico L, Croella F, Alfieri S, Fioretti F, Brunetti ND, Inciardi RM, Nodari S (2023) Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets. Front Cardiovasc Med 10:1157472. https:\/\/doi.org\/10.3389\/fcvm.2023.1157472","journal-title":"Front Cardiovasc Med"},{"key":"10353_CR163","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/0735-1097(94)90665-3","volume":"23","author":"RM Bersin","year":"1994","unstructured":"Bersin RM, Wolfe C, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, Henderson GN, de Marco T, Chatterjee K (1994) Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 23:1617\u20131624. https:\/\/doi.org\/10.1016\/0735-1097(94)90665-3","journal-title":"J Am Coll Cardiol"},{"key":"10353_CR164","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0002-9149(88)91306-9","volume":"61","author":"TJ Wargovich","year":"1988","unstructured":"Wargovich TJ, MacDonald RG, Hill JA, Feldman RL, Stacpoole PW, Pepine CJ (1988) Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61:65\u201370. https:\/\/doi.org\/10.1016\/0002-9149(88)91306-9","journal-title":"Am J Cardiol"},{"key":"10353_CR165","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/s0735-1097(88)80010-x","volume":"12","author":"JR Wilson","year":"1988","unstructured":"Wilson JR, Mancini DM, Ferraro N, Egler J (1988) Effect of dichloroacetate on the exercise performance of patients with heart failure. J Am Coll Cardiol 12:1464\u20131469. https:\/\/doi.org\/10.1016\/s0735-1097(88)80010-x","journal-title":"J Am Coll Cardiol"},{"key":"10353_CR166","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2013.03.019","volume":"109","author":"M Abdelmalak","year":"2013","unstructured":"Abdelmalak M, Lew A, Ramezani R, Shroads AL, Coats BS, Langaee T, Shankar MN, Neiberger RE, Subramony SH, Stacpoole PW (2013) Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab 109:139\u2013143. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.019","journal-title":"Mol Genet Metab"},{"key":"10353_CR167","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsboll T (2016) Investigators S.-. Semaglutide and Cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375:1834\u20131844. https:\/\/doi.org\/10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"10353_CR168","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/oby.23621","volume":"31","author":"Lingvay I., Brown-Frandsen K., Colhoun H. M., Deanfield J., Emerson S. S., Esbjerg S., Hardt-Lindberg S., Hovingh G. K., Kahn S. E., Kushner R. F., Lincoff A. M., Marso S. P., Fries T. M., Plutzky J., Ryan D. H., Group S. S.","year":"2023","unstructured":"Lingvay I., Brown-Frandsen K., Colhoun H. M., Deanfield J., Emerson S. S., Esbjerg S., Hardt-Lindberg S., Hovingh G. K., Kahn S. E., Kushner R. F., Lincoff A. M., Marso S. P., Fries T. M., Plutzky J., Ryan D. H., Group S. S. (2023) Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics. Obesity 31:111\u2013122. https:\/\/doi.org\/10.1002\/oby.23621","journal-title":"Obesity"},{"key":"10353_CR169","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/dom.15058","volume":"25","author":"DK McGuire","year":"2023","unstructured":"McGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter N, Engelmann MDM, Hovingh GK, Ripa MS, Gislum M, Brown-Frandsen K, Buse JB (2023) Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and\/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial. Diabetes Obes Metab 25:1932\u20131941. https:\/\/doi.org\/10.1111\/dom.15058","journal-title":"Diabetes Obes Metab"},{"key":"10353_CR170","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","volume":"11","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstrom SZ, Borlaug BA, Butler J, Christensen L, Davies M, Hovingh KG, Kitzman DW, Lindegaard ML, Moller DV, Shah SJ, Treppendahl MB, Verma S, Petrie MC (2023) Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype. JACC Heart failure 11:1000\u20131010. https:\/\/doi.org\/10.1016\/j.jchf.2023.05.010","journal-title":"JACC Heart failure"},{"key":"10353_CR171","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/cs0990027","volume":"99","author":"S Schmidt-Schweda","year":"2000","unstructured":"Schmidt-Schweda S, Holubarsch C (2000) First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin Sci 99:27\u201335","journal-title":"Clin Sci"},{"key":"10353_CR172","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/CS20060307","volume":"113","author":"CJ Holubarsch","year":"2007","unstructured":"Holubarsch CJ, Rohrbach M, Karrasch M, Boehm E, Polonski L, Ponikowski P, Rhein S (2007) A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study. Clin Sci 113:205\u2013212. https:\/\/doi.org\/10.1042\/CS20060307","journal-title":"Clin Sci"},{"key":"10353_CR173","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","volume":"112","author":"L Lee","year":"2005","unstructured":"Lee L, Campbell R, Scheuermann-Freestone M, Taylor R, Gunaruwan P, Williams L, Ashrafian H, Horowitz J, Fraser AG, Clarke K, Frenneaux M (2005) Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation 112:3280\u20133288. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.551457","journal-title":"Circulation"},{"key":"10353_CR174","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ehj.2004.02.018","volume":"25","author":"L Lee","year":"2004","unstructured":"Lee L, Horowitz J, Frenneaux M (2004) Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 25:634\u2013641. https:\/\/doi.org\/10.1016\/j.ehj.2004.02.018","journal-title":"Eur Heart J"},{"key":"10353_CR175","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10557-021-07259-y","volume":"37","author":"G Qian","year":"2023","unstructured":"Qian G, Jiang X, Jiang Z, Li T, Dong W, Guo J, Chen Y (2023) Early Trimetazidine therapy in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction reduces myocardial infarction size. Cardiovasc Drugs Ther 37:497\u2013506. https:\/\/doi.org\/10.1007\/s10557-021-07259-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"10353_CR176","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12872-021-02287-w","volume":"21","author":"ZL Dai","year":"2021","unstructured":"Dai ZL, Song YF, Tian Y, Li Y, Lin M, Lin J, Wang Q, Wang P, Gao WL (2021) Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial. BMC Cardiovasc Disord 21:473. https:\/\/doi.org\/10.1186\/s12872-021-02287-w","journal-title":"BMC Cardiovasc Disord"},{"key":"10353_CR177","doi-asserted-by":"publisher","first-page":"627","DOI":"10.5603\/CJ.a2020.0165","volume":"29","author":"M Bohdan","year":"2022","unstructured":"Bohdan M, Stopczynska I, Wisniewski P, Morys J, Niedoszytko P, Gruchala M (2022) Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: a prospective, randomized, open-label, cross-over study. Cardiol J 29:627\u2013636. https:\/\/doi.org\/10.5603\/CJ.a2020.0165","journal-title":"Cardiol J"},{"key":"10353_CR178","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5582\/ddt.2022.01020","volume":"16","author":"RP Harjoko","year":"2022","unstructured":"Harjoko RP, Sobirin MA, Uddin I, Bahrudin U, Maharani N, Herminingsih S, Tsutsui H (2022) Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease. Drug Discov Ther 16:177\u2013184. https:\/\/doi.org\/10.5582\/ddt.2022.01020","journal-title":"Drug Discov Ther"},{"key":"10353_CR179","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, Moller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frokiaer J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, Botker HE, Wiggers H (2019) Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation 139:2129\u20132141. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036459","journal-title":"Circulation"},{"key":"10353_CR180","doi-asserted-by":"crossref","unstructured":"Monzo L, Sedlacek K, Hromanikova K, Tomanova L, Borlaug BA, Jabor A, Kautzner J, Melenovsky V (2021) Myocardial ketone body utilization in patients with heart failure: the impact of oral ketone ester. Metab Clin Exp 115","DOI":"10.1016\/j.metabol.2020.154452"},{"key":"10353_CR181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.05.029","author":"K Berg-Hansen","year":"2023","unstructured":"Berg-Hansen K, Christensen KH, Gopalasingam N, Nielsen R, Eiskjaer H, Moller N, Birkelund T, Christensen S, Wiggers H (2023) Beneficial effects of ketone ester in patients with cardiogenic shock: a randomized, controlled, double-blind trial. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2023.05.029","journal-title":"JACC Heart Fail"},{"key":"10353_CR182","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Belohlavek J, Bohm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Dukat A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sjostrand M, Langkilde AM, Committees D-HT (2019) Investigators, Dapagliflozin in Patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"key":"10353_CR183","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Pina IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M, Investigators EM-PT (2021) Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 385:1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038","journal-title":"N Engl J Med"},{"key":"10353_CR184","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamacardio.2023.1090","volume":"8","author":"J Butler","year":"2023","unstructured":"Butler J, Usman MS, Filippatos G, Ferreira JP, Bohm M, Brueckmann M, Januzzi JL, Kaul S, Pina IL, Ponikowski P, Senni M, Sumin M, Verma S, Zaremba-Pechmann L, Pocock SJ, Packer M, Anker S (2023) Safety and efficacy of empagliflozin and diuretic use in patients with heart failure and preserved ejection fraction: a post hoc analysis of the EMPEROR-preserved Trial. JAMA Cardiol 8:640\u2013649. https:\/\/doi.org\/10.1001\/jamacardio.2023.1090","journal-title":"JAMA Cardiol"},{"key":"10353_CR185","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","volume":"10","author":"J Tromp","year":"2022","unstructured":"Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, Anand IS, Lam CSP, Voors AA (2022) A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC Heart Fail 10:73\u201384. https:\/\/doi.org\/10.1016\/j.jchf.2021.09.004","journal-title":"JACC Heart Fail"},{"key":"10353_CR186","doi-asserted-by":"publisher","unstructured":"Saucedo-Orozco H, Voorrips SN, Yurista SR, de Boer RA, Westenbrink BD (2022) SGLT2 inhibitors and ketone metabolism in heart failure. J Lipid Atheroscler 11:1\u201319. https:\/\/doi.org\/10.12997\/jla.2022.11.1.1","DOI":"10.12997\/jla.2022.11.1.1"},{"key":"10353_CR187","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1161\/CIRCULATIONAHA.122.062021","volume":"147","author":"MJ Hundertmark","year":"2023","unstructured":"Hundertmark MJ, Adler A, Antoniades C, Coleman R, Griffin JL, Holman RR, Lamlum H, Lee J, Massey D, Miller J, Milton JE, Monga S, Mozes FE, Nazeer A, Raman B, Rider O, Rodgers CT, Valkovic L, Wicks E, Mahmod M, Neubauer S (2023) Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial. Circulation 147:1654\u20131669. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062021","journal-title":"Circulation"},{"key":"10353_CR188","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.122.060402","volume":"146","author":"S Selvaraj","year":"2022","unstructured":"Selvaraj S, Fu Z, Jones P, Kwee LC, Windsor SL, Ilkayeva O, Newgard CB, Margulies KB, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Lanfear DE, Nassif ME, Javaheri A, Mentz RJ, Kosiborod MN, Shah SH, Investigators D-H (2022) Metabolomic profiling of the effects of dapagliflozin in heart failure with reduced ejection fraction: DEFINE-HF. Circulation 146:808\u2013818. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060402","journal-title":"Circulation"},{"key":"10353_CR189","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2337\/dc16-0330","volume":"39","author":"E Ferrannini","year":"2016","unstructured":"Ferrannini E, Mark M, Mayoux E (2016) CV Protection in the EMPA-REG OUTCOME Trial: a \u201cthrifty substrate\u201d hypothesis. Diabetes Care 39:1108\u20131114. https:\/\/doi.org\/10.2337\/dc16-0330","journal-title":"Diabetes Care"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:23:05Z","timestamp":1709198585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":189,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10353"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10353-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"19 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}